The choice to try a drug is a decision that that is centered in the executive portion of the brain, the prefrontal cortex. Once consumed, the drug delivers a powerful stimulus to the nucleus ...

"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical literature that these drugs could ... 6 percent of cortex according ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

A new Yale study, however, has identified a molecular mechanism that underlies some lissencephaly disorders — and a drug that prevents and reverses ... also have a thicker than usual cerebral cortex.

Scientists at Stanford Medicine are advancing the understanding of schizophrenia by creating a "periodic table" for ...

"Understanding the complex interplay between the factors that contribute and that protect against drug use ... depth of brain folds, and surface area, primarily in the brain cortex.

The choice to try a drug is a decision that that is centered in the executive portion of the brain, the prefrontal cortex. Once consumed, the drug delivers a powerful stimulus to the nucleus ...

A new Yale study, however, has identified a molecular mechanism that underlies some lissencephaly disorders—and a drug that prevents ... a thicker than usual cerebral cortex.